COVID-19 shot tested to stop type 1 diabetes in kids

NCT ID NCT06452654

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether giving the COVID-19 vaccine (Comirnaty) to children starting at 6 months old can lower their chance of developing type 1 diabetes. The trial will include 2,252 children who have a high genetic risk for the disease. Half will get the vaccine, half a placebo, and researchers will track who develops diabetes-related antibodies or type 1 diabetes over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
COVID-19 vaccine (Comirnaty)
What this could lead to
If it works, this could show that COVID-19 vaccination helps prevent type 1 diabetes in children with a high genetic risk.
What could go wrong
This is a large but early-stage prevention trial. It may not prove that the vaccine reduces diabetes risk, and results may take years. The vaccine has known side effects like fever or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AUF DER BULT, Kinder- und Jugendkrankenhaus

    RECRUITING

    Hanover, Lower Saxony, 30173, Germany

  • Birmingham Women's and Children's NHS Foundation Trust

    NOT_YET_RECRUITING

    Birmingham, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust

    NOT_YET_RECRUITING

    Cambridge, United Kingdom

  • Klinik und Poliklinik f. Kinder und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden

    RECRUITING

    Dresden, Saxony, 01307, Germany

  • Klinikum rechts der Isar of Technical University Munich and Institute for Diabetes Research, Helmholtz Munich

    RECRUITING

    Munich, Bavaria, 80939, Germany

  • Lund University Dep. of Clinical Sciences Malmo, Skane University Hospital SUS

    RECRUITING

    Malmö, 20213, Sweden

  • Medical University of Vienna, Dept. of Pediatric and Adolescent Medicine, Waehringer Gürtel 18-20, 1090 Vienna, Austria

    NOT_YET_RECRUITING

    Vienna, 1090, Austria

  • The Newcastle upon Tyne Hospitals NHS Foundation Trust

    RECRUITING

    Newcastle, United Kingdom

  • University Hospitals Leuven, Faculty of Medicine, Catholic University of Leuven

    RECRUITING

    Leuven, 3000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.